Masaki Ri

Bortezomib-resistant myeloma cell lines: a role for mutated PSMB5 in preventing the accumulation of unfolded proteins and fatal ER stress

Masaki Ri, Shinsuke Iida, Takayuki Nakashima et al. · Leukemia · 2010 · 180 citations

Hematological Malignancy, Mutated Psmb5, Unfolded Proteins +7

Identification of Toyocamycin, an agent cytotoxic for multiple myeloma cells, as a potent inhibitor of ER stress-induced XBP1 mRNA splicing

Masaki Ri, Etsu Tashiro, Daisuke Oikawa et al. · Blood Cancer Journal · 2012 · 180 citations · Full text

Potent Inhibitor, Molecular Regulation, Molecular Biology +20

Rapid Discovery of Highly Potent and Selective Inhibitors of Histone Deacetylase 8 Using Click Chemistry to Generate Candidate Libraries

Takayoshi Suzuki, Yosuke Ota, Masaki Ri et al. · Journal of Medicinal Chemistry · 2012 · 152 citations · Full text

Peptide Science, Hdac8-selective Inhibitors, Click Chemistry +21

Defucosylated anti-CCR4 monoclonal antibody exercises potent ADCC-mediated antitumor effect in the novel tumor-bearing humanized NOD/Shi-scid, IL-2Rγnull mouse model

Asahi Ito, Takashi Ishida, Hiroki Yano et al. · Cancer Immunology Immunotherapy · 2008 · 126 citations · Full text

Shikonin, dually functions as a proteasome inhibitor and a necroptosis inducer in multiple myeloma cells

Naoko Wada, Yawara Kawano, Shiho Fujiwara et al. · International Journal of Oncology · 2014 · 72 citations · Full text

Necroptosis Inducer, Mw 288.3, Apoptosis +18